Fluidigm Corporation
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consum… Read more
Fluidigm Corporation (FLB) - Total Liabilities
Latest total liabilities as of September 2025: €139.98 Million EUR
Based on the latest financial reports, Fluidigm Corporation (FLB) has total liabilities worth €139.98 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fluidigm Corporation - Total Liabilities Trend (2015–2024)
This chart illustrates how Fluidigm Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Fluidigm Corporation Competitors by Total Liabilities
The table below lists competitors of Fluidigm Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Orient Technologies Limited
NSE:ORIENTTECH
|
India | ₹2.42 Billion |
|
SeA Mechanics Co. Ltd.
KQ:396300
|
Korea | ₩75.39 Billion |
|
PRICELINE.COM - Dusseldorf Stock Exchang
DU:PCE1
|
Germany | €31.63 Billion |
|
Seronics Co. Ltd
KQ:042600
|
Korea | ₩118.34 Billion |
|
Alicon Castalloy Limited
NSE:ALICON
|
India | ₹7.09 Billion |
|
Cho Kwang Leat
KO:004700
|
Korea | ₩77.74 Billion |
|
FORTEC Elektronik AG
F:FEV
|
Germany | €18.79 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Fluidigm Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fluidigm Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fluidigm Corporation (2015–2024)
The table below shows the annual total liabilities of Fluidigm Corporation from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €140.62 Million | -70.15% |
| 2023-12-31 | €471.12 Million | -0.14% |
| 2022-12-31 | €471.78 Million | +161.20% |
| 2021-12-31 | €180.62 Million | -2.74% |
| 2020-12-31 | €185.71 Million | +67.00% |
| 2019-12-31 | €111.20 Million | -51.97% |
| 2018-12-31 | €231.53 Million | -9.70% |
| 2017-12-31 | €256.42 Million | +1.29% |
| 2016-12-31 | €253.16 Million | -0.78% |
| 2015-12-31 | €255.15 Million | -- |